mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize With PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-1772
Full Text
Open PDFAbstract
Available in full text
Date
November 6, 2015
Authors
Publisher
American Association for Cancer Research (AACR)